Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Urology Academy Of MedfiledCriticalInst Of Urology Academy Of Med
Priority to UA20031110004ApriorityCriticalpatent/UA67597A/en
Publication of UA67597ApublicationCriticalpatent/UA67597A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The method for treating prostate cancer comprises the use of Flutamide per os at a daily dose of 500 mg, four times by 125 mg each six hours for 3-6 months.
UA20031110004A2003-11-062003-11-06Method for treating prostate cancer
UA67597A
(en)
Compound, composition, methods for modulating ksp kinesin activity, for inhibiting ksp, for the treatment of a cell proliferative disease, and use of a compound